April 06, 2009 -- Sinobiopharma, Inc. is pleased to announce that it has applied for a single Chinese patent for new drug compounds containing Perindopril, an angiotensin-converting enzyme inhibitor used to treat high blood pressure (hypertension) and heart attack in people with coronary artery disease.
The details can be read here.
No comments:
Post a Comment